Implications and development of AHR-based therapeutic agents

Eun Young Choi, Hyosung Lee, R. W.Cameron Dingle, Kyung Bo Kim, Hollie I. Swanson

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


The emerging role of the AHR in modulating disease processes such as the immune and inflammatory responses, indicates a need for AHR-based investigative tools and therapeutic agents. Since the AHR has historically been aligned with the adverse biological effects of environmental contaminants, setting the stage for its potential role as a therapeutic target requires the use of a different lens through which to view its actions. This alternative perspective is enhanced by the discovery and further study of endogenous AHR agonists, "pure" AHR antagonists and unique SARMS. Towards this end, the discoveries that AHR agonists can alleviate inflammatory-induced disease severity in preclinical animal models coupled with the identification of SARMs (i.e., AL-3) identifies novel approaches to be used for treating many chronic inflammatory disease states. Further, the recent identification of an endogenous, tumor-promoting AHR agonist, when coupled with our improved understanding of the rules that govern the activities of AHR antagonists (i.e., CH223191), will likely lead to AHR antagonists with chemotherapeutic properties. These small, but significant strides represent only a glimpse of the future advances that will be made in the development of AHR-based therapeutic agents.

Original languageEnglish
Pages (from-to)53-60
Number of pages8
JournalMolecular and Cellular Pharmacology
Issue number2
StatePublished - 2012


  • 2-methyl-2H-pyrazole-3-carboxylic acid
  • 6-formylindo[3,2-b]carbazole
  • Aryl hydrocarbon receptor
  • Cytochrome P450 1A1
  • Estrogen receptor

ASJC Scopus subject areas

  • Molecular Biology
  • Pharmaceutical Science


Dive into the research topics of 'Implications and development of AHR-based therapeutic agents'. Together they form a unique fingerprint.

Cite this